Effect of Proton-Pump Inhibitor Therapy on Serum Chromogranin A Level.

2011 
Background: The neuroendocrine marker, chromogranin A (CgA) increases during medium- or long-term proton-pump inhibitor (PPI) treatment. Aims: To analyze the effe
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    34
    References
    56
    Citations
    NaN
    KQI
    []